RecruitingNCT07402161

The Signature of Alzheimer's Disease in Subjective Cognitive Decline

Studying NON RARE IN EUROPE: Alzheimer disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
IRCCS Policlinico S. Donato
Principal Investigator
Salvatore Mazzeo, MD, PhD
Università Vita-Salute San Raffaele, Milano - Neurology Unit, IRCCS Policlinico San Donato, San Donato Milanese
Enrollment
250 enrolled
Eligibility
18 years · All sexes
Timeline
2025 – 2028

Study locations (1)

Collaborators

Azienda Ospedaliero-Universitaria Careggi

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07402161 on ClinicalTrials.gov

Other trials for NON RARE IN EUROPE: Alzheimer disease

Additional recruiting or active studies for the same condition.

See all trials for NON RARE IN EUROPE: Alzheimer disease →

← Back to all trials